M-M-R II

מדינה: אוסטרליה

שפה: אנגלית

מקור: Department of Health (Therapeutic Goods Administration)

מרכיב פעיל:

Rubella virus; Mumps virus; Measles virus

זמין מ:

Merck Sharp & Dohme Australia Pty Ltd

סיווג:

Medicine Registered

עלון מידע

M-M-R II
®

_Measles, Mumps and Rubella Virus Vaccine Live_
CONSUMER MEDICINE INFORMATION

WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about M-M-R II. It does
not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
All medicines and vaccines have
risks and benefits. Your doctor has
weighed the risks of you being given
M-M-R II against the benefits they
expect it will have for you.
IF YOU HAVE ANY CONCERNS ABOUT
BEING GIVEN THIS VACCINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET.
You may need to read it again.
WHAT M-M-R II IS USED
FOR
M-M-R II is a vaccine used to help
protect people from getting measles,
mumps and rubella (German
measles). It can be given to people 12
- 15 months of age and older.
Protection against these infections is
important as they can cause serious
problems in some people.
Measles is a serious disease that
causes a high fever (temperature),
runny nose, cough, conjunctivitis and
a rash. It usually lasts for about 1 to 2
weeks. It is very easily passed from
one person to another in the tiny
droplets of moisture which are
expelled during coughing or
sneezing. One out of every 10
children who catch measles will also
have an ear infection or pneumonia.
On rare occasions, measles can also
cause an infection of the brain that
could lead to seizures, hearing loss,
mental retardation, and even death.
Babies and adults who catch measles
are often much sicker for a longer
time or are more likely to die than
school children and teenagers who
catch measles.
Mumps causes fever, headache, and
swollen, painful glands under the jaw
(salivary glands) and usually lasts
several days. It is easily passed from
one person to another by the tiny
droplets of moisture expelled during
coughing or sneezing. Mumps can
sometimes be a very serious disease,
causing a mild inflammation of the
coverings of the brain and spinal cord
(meningitis) in about one person in
every 10 who catch it. About one out
of every 4 teenage or

מאפייני מוצר

MMR-122007 

1 
PRODUCT INFORMATION 

NAME OF MEDICINE 

M-M-R
®
 II 

(Measles, Mumps and Rubella Virus Vaccine Live, MSD) 

DESCRIPTION 

M-M-R
®
 II (Measles, Mumps and Rubella Virus Vaccine Live, MSD) is a live virus vaccine for 
immunisation against measles (rubeola), mumps and rubella
(German measles). 

M-M-R  II  is  a  sterile  lyophilised  preparation  containing  a  more  attenuated  line  of  measles 
virus, derived from Enders' attenuated Edmonston strain and grown in cell cultures of chick 
embryo;  the  Jeryl  Lynn  (B  level)  strain  of  mumps  virus  grown  in  cell  cultures  of  chick 
embryo;  and  the  Wistar  RA  27/3  strain  of  live  attenuated  rubella  virus  grown  in  human 
diploid  cell  (WI-38)  culture.    The  rubella  vaccine  virus  is  the  same  as  that  used  in  the 
manufacture  of  MERUVAX  II®  (Rubella  Virus  Vaccine  Live,  MSD).    The  three  viruses  are 
mixed before being lyophilised.   

The  reconstituted  vaccine  is  for  subcutaneous  administration.    When  reconstituted  as 
directed,  the  dose  for  injection  is  0.5mL  and  contains  not  less  than  the equivalent  of 1000 
TCID50 (50% tissue culture infectious doses) of Measles Virus;  12,500 TCID50 of Mumps 
Virus; and 1000 TCID50 of Rubella Virus.  Each dose of the vaccine contains sorbitol (14.5 
mg),  sodium  phosphate,  sucrose  (1.9  mg),  sodium  chloride,  hydrolysed  gelatin  (14.5  mg), 
recombinant  human  albumin  (
≤0.3  mg),  foetal  bovine  serum  (<1ppm),  other  buffer  and 
media  ingredients  and  approximately  2